Prevalence of self-reported erectile dysfunction among urological cases in Turkish men

Urology Journal

Volumn 8, Issue 3, 2011, Pages 214-221

  Bayraktar, Zeki ^a   Atun, Ihsan ^a  

^a Department of Urology   (Turkey)

Author keywords

Erectile dysfunction; Icd 10; Medical records; Prevalence

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; ERECTILE DYSFUNCTION; HUMAN; MALE; MIDDLE AGED; PREVALENCE; SELF REPORT; TURKEY (REPUBLIC);

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ERECTILE DYSFUNCTION; HUMANS; MALE; MIDDLE AGED; PREVALENCE; SELF REPORT; TURKEY; YOUNG ADULT;

EID: 84855548714     PISSN: 17351308     EISSN: 1735546X     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Feldman HA, Goldstein I, Hatzichristou DG, Krane RJ, McKinlay JB. Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study. J Urol. 1994;151:54-61.
2. Chew KK, Bremner A, Stuckey B, Earle C, Jamrozik K. Is the relationship between cigarette smoking and male erectile dysfunction independent of cardiovascular disease? Findings from a populationbased cross-sectional study. J Sex Med. 2009;6: 222-31.
3. Lewis RW. Epidemiology of sexual dysfunction in Asia compared to the rest of the world. Asian J Androl. 2011;13:152-8.
4. Selvin E, Burnett AL, Platz EA. Prevalence and risk factors for erectile dysfunction in the US. Am J Med. 2007;120:151-7.
5. Andersen ML, Santos-Silva R, Bittencourt LR, Tufik S. Prevalence of erectile dysfunction complaints associated with sleep disturbances in Sao Paulo, Brazil: a population-based survey. Sleep Med. 2010;11:1019-24.
6. Giuliano F, Chevret-Measson M, Tsatsaris A, Reitz C, Murino M, Thonneau P. Prevalence of erectile dysfunction in France: results of an epidemiological survey of a representative sample of 1004 men. Eur Urol. 2002;42:382-9.
7. Moreira Jr. ED, , Lbo CF, Diament A, Nicolosi A, Glasser DB. Incidence of erectile dysfunction in men 40 to 69 years old: results from a population-based cohort study in Brazil. Urology. 2003;61:431-6.
8. Nicolosi A, Moreira Jr. ED, , Shirai M, Bin Mohd Tambi MI, Glasser DB. Epidemiology of erectile dysfunction in four countries: cross-national study of the prevalence and correlates of erectile dysfunction. Urology. 2003;61:201-6.
9. Teles AG, Carreira M, Alarcao V, et al. Prevalence, severity, and risk factors for erectile dysfunction in a representative sample of 3,548 portuguese men aged 40 to 69 years attending primary healthcare centers: results of the Portuguese erectile dysfunction study. J Sex Med. 2008;5:1317-24.
10. Akkus E, Kadioglu A, Esen A, et al. Prevalence and correlates of erectile dysfunction in Turkey: a population-based study. Eur Urol. 2002;41:298-304.
11. Kendirci M, Trost L, Sikka SC, Hellstrom WJ. The effect of vascular risk factors on penile vascular status in men with erectile dysfunction. J Urol. 2007;178:2516-20; discussion 20.
12. Blumentals WA, Gomez-Caminero A, Joo S, Vannappagari V. Should erectile dysfunction be considered as a marker for acute myocardial infarction? Results from a retrospective cohort study. Int J Impot Res. 2004;16:350-3.
13. Doumas M, Tsakiris A, Douma S, et al. Factors affecting the increased prevalence of erectile dysfunction in Greek hypertensive compared with normotensive subjects. J Androl. 2006;27:469-77.
14. Malavige LS, Levy JC. Erectile dysfunction in diabetes mellitus. J Sex Med. 2009;6:1232-47.
15. Hebert K, Anand J, Trahan P, et al. Prevalence of erectile dysfunction in systolic heart failure patients in a developing country: Tbilisi, Georgia, Eastern Europe. J Sex Med. 2010;7:3991-6.
16. Bal K, Oder M, Sahin AS, et al. Prevalence of metabolic syndrome and its association with erectile dysfunction among urologic patients: metabolic backgrounds of erectile dysfunction. Urology. 2007;69:356-60.
17. Bouwman, II, Van Der Heide WK, Van Der Meer K, Nijman R. Correlations between lower urinary tract symptoms, erectile dysfunction, and cardiovascular diseases: are there differences between male populations from primary healthcare and urology clinics? A review of the current knowledge. Eur J Gen Pract. 2009;15:128-35.
18. Hao ZY, Li HJ, Wang ZP, et al. The prevalence of erectile dysfunction and its relation to chronic prostatitis in chinese men. J Androl. 2011;32:496-501.
19. Mehraban D, Naderi GH, Yahyazadeh SR, Amirchaghmaghi M. Sexual dysfunction in aging men with lower urinary tract symptoms. Urol J. 2008;5: 260-4.
20. Hoesl CE, Woll EM, Burkart M, Altwein JE. Erectile dysfunction (ED) is prevalent, bothersome and underdiagnosed in patients consulting urologists for benign prostatic syndrome (BPS). Eur Urol. 2005;47:511-7.
21. Sanchez-Cruz JJ, Cabrera-Leon A, Martin-Morales A, Fernandez A, Burgos R, Rejas J. Male erectile dysfunction and health-related quality of life. Eur Urol. 2003;44:245-53.
22. Ayta IA, McKinlay JB, Krane RJ. The likely worldwide increase in erectile dysfunction between 1995 and 2025 and some possible policy consequences. BJU Int. 1999;84:50-6.
23. Cho BL, Kim YS, Choi YS, et al. Prevalence and risk factors for erectile dysfunction in primary care: results of a Korean study. Int J Impot Res. 2003;15:323-8.
24. McKinlay JB. The worldwide prevalence and epidemiology of erectile dysfunction. Int J Impot Res. 2000;12 Suppl 4:S6-S11.
25. Wong SY, Leung JC, Woo J. Sexual activity, erectile dysfunction and their correlates among 1,566 older Chinese men in Southern China. J Sex Med. 2009;6:74-80.
26. Khoo EM, Tan HM, Low WY. Erectile dysfunction and comorbidities in aging men: an urban cross-sectional study in Malaysia. J Sex Med. 2008;5:2925-34.
27. Droupy S, Giuliano F, Cuzin B, Costa P, Vicaut E, Levrat F. [Prevalence of erectile dysfunction in patients consulting urological clinics: the ENJEU survey (one day national survey on prevalence of male sexual dysfunction among men consulting urologists)]. Prog Urol. 2009;19:830-8.
28. Uluocak N, Sanli O, Gul H, et al. A population based epidemiological study on benign prostatic obstruction in a suburban district of Istanbul. Turkish J Urol. 2009;35:170-9.
29. Karakose A, Alp T, Guner ND, Citlak MB, Aydin S. The place of andrological cases in our general urology practice. Turkish J Urol. 2010;36:49-54.
30. Bayraktar Z, Atun I. The rate of use of phosphodiesterase-5 (PDE5) inhibitor without physician recommendation and the faults of using medication in patients with erectile dysfunction. New J Urol. 2011;6:26-31.